diaDexus Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
17,376.00
13,598.00
16,847.00
14,946.00
9,116.00
Total Accounts Receivable
2,408.00
2,789.00
3,027.00
4,101.00
1,704.00
Inventories
117.00
134.00
460.00
578.00
186.00
Other Current Assets
1,279.00
1,171.00
845.00
500.00
398.00
Total Current Assets
21,180.00
17,692.00
21,179.00
20,125.00
11,404.00
Net Property, Plant & Equipment
1,350.00
1,250.00
968.00
637.00
302.00
Total Investments and Advances
1,650.00
1,400.00
1,400.00
1,400.00
1,400.00
Other Assets
175.00
142.00
100.00
131.00
49.00
Total Assets
24,355.00
20,484.00
23,647.00
22,293.00
13,155.00
ST Debt & Current Portion LT Debt
864.00
860.00
3,460.00
1,777.00
14,357.00
Accounts Payable
882.00
469.00
611.00
1,023.00
737.00
Income Tax Payable
126.00
-
-
-
-
Other Current Liabilities
2,674.00
2,270.00
2,482.00
3,322.00
2,181.00
Total Current Liabilities
4,546.00
3,599.00
6,553.00
6,122.00
17,275.00
Long-Term Debt
7,589.00
7,096.00
8,824.00
14,748.00
-
Other Liabilities
1,080.00
934.00
750.00
577.00
591.00
Total Liabilities
13,215.00
11,629.00
16,127.00
21,447.00
17,866.00
Common Equity (Total)
11,140.00
8,855.00
7,520.00
846.00
4,711.00
Total Shareholders' Equity
11,140.00
8,855.00
7,520.00
846.00
4,711.00
Total Equity
11,140.00
8,855.00
7,520.00
846.00
4,711.00
Liabilities & Shareholders' Equity
24,355.00
20,484.00
23,647.00
22,293.00
13,155.00

About diaDexus

View Profile
Address
349 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.diadexus.com
Updated 07/08/2019
Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. It operates through the following geographical segments: United States, Europe, and Rest of the World. Its portfolio intends to treat cardiovascular diseases.